Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Intelligent Bio-Systems Inc (AKA: IBS)
Profile last edited on: 9/3/19      CAGE: 46RB7      UEI:

Business Identifier: DNA sequencing system
Year Founded
2004
First Award
2005
Latest Award
2013
Program Status
Inactive (Acquired)
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

34 Bear Hill Road
Waltham, MA 02451
Location: Single
Congr. District: 05
County: Middlesex

Public Profile

In June 2012, Intelligent Bio-Systems Inc was acquired by Quiagen N.V., a large life sciences research tools company. Intelligent Bio-Systems is developing new biochemical and instrumentation technologies related to DNA and RNA analysis for research and diagnostic applications: NGS instruments for applications in clinical research and molecular diagnostics. IBS has licensed technology from Columbia University for the low-cost, high-throughput sequencing of DNA segments

Extent of SBIR involvement

User Avatar
Phase I Awards
6
Phase II Awards
5
Conversion Rate
83.33%
Phase I Dollars
$1,015,802
Phase II Dollars
$10,056,956
Total Awarded
$11,072,758

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2013 2 NIH $3,502,953
Project Title: Novel Diagnostic Sequencing System for HIV Resistance Testing
2013 2 NIH $1,719,004
Project Title: Digital Gene Expression for Cancer
2012 2 NIH $1,638,683
Project Title: Novel Cleavable Nucleotides for DNA Sequencing by Synthesis
2011 2 NIH $3,229,278
Project Title: Ordered Arrays for Advanced Sequencing Systems
2009 2 NIH $1,632,915
Project Title: Streamlined Template Preparation for Advanced Sequencing Methods

Key People / Management

  Steven J Gordon -- President

Company News

Jun 26 2012
Qiagen Acquires Intelligent Bio-Systems, Maps Out Sequencing Strategy